(Q33540751)

English

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin (English)

1 reference

Europe PubMed Central

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gewirtz DA

1

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

27 July 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

27 July 2017

57

1 reference

Europe PubMed Central

27 July 2017

727-741

1 reference

Europe PubMed Central

27 July 2017

7

1 reference

Europe PubMed Central

27 July 2017

Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Some effects of daunomycin on the nucleic acid synthesis in synchronized L-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interaction of daunomycin and its derivatives with DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin and Daunorubicin Inhibition of Mutant T4 DNA Polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The inhibition in vitro of DNA polymerase and RNA polymerases by daunomycin and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The Interaction of Daunomycin with Polydeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Mechanism of the inhibition of calf thymus DNA polymerases alpha and beta by daunomycin and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline antibiotics. Interaction with DNA and nucleosomes and inhibition of DNA synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Growth arrest and non-apoptotic cell death associated with the suppression of c-myc expression in MCF-7 breast tumor cells following acute exposure to doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Deoxyribose breakdown by the adriamycin semiquinone and H2O2: evidence for hydroxyl radical participation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Oxidative destruction of DNA by the adriamycin-iron complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Hydroxyl radical production and DNA damage induced by anthracycline-iron complex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radical damage to deoxyribose by anthracycline, aureolic acid and aminoquinone antitumour antibiotics. An essential requirement for iron, semiquinones and hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radicals in anticancer drug pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin-induced oxygen free radical formation in sensitive and doxorubicin-resistant variants of rat glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dependence of nucleic acid degradation on in situ free-radical production by adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Two mechanisms of adriamycin-DNA interaction in L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced lipid peroxidation in mitochondria and microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Lipid peroxidation, phosphoinositide turnover and protein kinase C activation in human platelets treated with anthracyclines and their complexes with Fe(III)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Measurement of doxorubicin-induced lipid peroxidation under the conditions that determine cytotoxicity in cultured tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Evaluation of adriamycin-induced lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA sequence-specific adducts of adriamycin and mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Induction of stable transcriptional blockage sites by Adriamycin: GpC specificity of apparent Adriamycin-DNA adducts and dependence on iron(III) ions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The consequences of doxorubicin quinone reduction in vivo in tumour tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Formation of adriamycin--DNA adducts in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interstrand DNA crosslinking induced by anthracyclines in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA unwinding and inhibition of T4 DNA ligase by anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Correlation between anthracycline structure and human DNA ligase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline antibiotic blockade of SV40 T antigen helicase action.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline glycoside-membrane interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The anticancer agent adriamycin can be actively cytotoxic without entering cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Pharmacokinetics and metabolism of adriamycin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

PCNA: structure, functions and interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Clinical pharmacokinetics of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Protective role of the glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Development of mechanisms of protection against oxidative stress in doxorubicin-resistant rat tumoral cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Free radical modes of cytotoxicity of adriamycin and streptonigrin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Early and delayed clinical cardiotoxicity of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interactions of adriamycin aglycones with mitochondria may mediate adriamycin cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Use of ICRF-187 for prevention of anthracycline cardiotoxicity in children: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Serum lipid peroxides in rats treated chronically with adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The role of lipid peroxidation in acute doxorubicin-induced cardiotoxicity as studied in rat isolated heart

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin induced alterations in lipid metabolism of cultured myocardial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

DNA double-strand breaks in mammalian cells after exposure to intercalating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Repair of deoxyribonucleic acid lesions caused by adriamycin and ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracyclines with different sequence specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Influence of ionizing radiation on proliferation, c-myc expression and the induction of apoptotic cell death in two breast tumour cell lines differing in p53 status

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The Cause of G2-Arrest in Chinese Hamster Ovary Cells Treated With Anticancer Drugs2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

G2 block induced by DNA crosslinking agents and its possible consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

p16INK4A participates in a G1 arrest checkpoint in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Dose-dependence of doxorubicin effect on actin assembly in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

The molecular pharmacology of doxorubicin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

Doxorubicin resistance conferred by selective enhancement of intracellular glutathione peroxidase or superoxide dismutase content in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900307-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00307-4

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33540751&oldid=1584572790"